Invention Grant
- Patent Title: Cancer treatment and immune system regulation through FAT10 pathway inhibition
-
Application No.: US15474320Application Date: 2017-03-30
-
Publication No.: US10167469B2Publication Date: 2019-01-01
- Inventor: Yifat Merbl , Marc W. Kirschner
- Applicant: President and Fellows of Harvard College
- Applicant Address: US MA Cambridge
- Assignee: President and Fellows of Harvard College
- Current Assignee: President and Fellows of Harvard College
- Current Assignee Address: US MA Cambridge
- Agency: Foley Hoag LLP
- Agent DeAnn F. Smith; Brendan T. Jones
- Main IPC: C07H21/02
- IPC: C07H21/02 ; C07H21/04 ; A61K48/00 ; C12N15/113 ; G01N33/50 ; A61K31/7105 ; A61K31/713 ; G01N33/68 ; A01K67/027 ; C07K14/00
Abstract:
Described herein are methods of inhibiting mitosis, treating cancer and/or treating immune disorders through the use of agents that inhibit FAT10 and/or the FAT10 pathway.
Public/Granted literature
- US20170275623A1 CANCER TREATMENT AND IMMUNE SYSTEM REGULATION THROUGH FAT10 PATHWAY INHIBITION Public/Granted day:2017-09-28
Information query
